SEARCH

SEARCH BY CITATION

References

  • Abbas A. I., Yadav P. N., Yao W.-D., Arbuckle M. I., Grant S. G. N., Caron M. G. and Roth B. L. (2009) PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors. J. Neurosci. 29, 71247136.
  • Abdallah L., Bonasera S. J., Hopf F. W. et al. (2009) Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. J. Neurosci. 29, 81568165.
  • Abercrombie E. D. and DeBoer P. (1997) Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. J. Neurosci. 17, 84988505.
  • Akema T., He D. and Sugiyama H. (2005) Lipopolysaccharide increases gamma-amminobutyric acid synthesis in medial preoptic neurons in association with inhibition of steriod-induced luteinising hormone surge in female rats. J. Neuroendocrinology 17, 672678.
  • Alex K. D. and Pehek E. A. (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 113, 296320.
  • Alex K. D., Yavanian G. J., McFarlane H. G., Pluto C. P. and Pehek E. A. (2005) Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55, 242251.
  • Araneda R. and Andrade R. (1991) 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40, 399412.
  • Blomeley C. and Bracci E. (2005) Excitatory effects of serotonin on rat striatal cholinergic interneurones. J. Physiol. 569, 715721.
  • Blomeley C. P. and Bracci E. (2009) Serotonin excites fast-spiking interneurons in the striatum. Eur. J. Neurosci. 29, 16041614.
  • Bolam J. P. and Smith Y. (1990) The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat. Brain Res. 529, 5778.
  • Bolam J. P., Hanley J. J., Booth P. A. C. and Bevan M. D. (2000) Synaptic organisation of the basal ganglia. J. Anat. 196, 527542.
  • Bonsi P., Cuomo D., Ding J., Sciamanna G., Ulrich S., Tscherter A., Bernardi G., Surmeier D. J. and Pisani A. (2007) Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology 32, 18401854.
  • Chuhma N., Tanaka K. F., Hen R. and Rayport S. (2011) Functional connectome of the striatal medium spiny neuron. J. Neurosci. 31, 11831192.
  • Clemett D. A., Punhani T., Duxon M. S., Blackburn T. P. and Fone K. C. (2000) Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology 39, 123132.
  • Cryan J. F. and Lucki I. (2000) Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. J. Pharmacol. Exp. Ther. 295, 11201126.
  • De Deurwaerdere P. and Spampinato U. (1999) Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J. Neurochem. 73, 10331042.
  • De Deurwaerdère P., Navailles S., Berg K. A., Clarke W. P. and Spampinato U. (2004) Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J. Neurosci. 24, 32353241.
  • De Deurwaerdère P., Lagière M., Bosc M. and Navailles S. (2013) Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology. Exp. Brain Res. 230, 477511.
  • Di Giovanni G., De Deurwaerdére P., Di Mascio M., Di Matteo V., Esposito E. and Spampinato U. (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91, 587597.
  • Di Giovanni G., Di Matteo V., Pierucci M., Benigno A. and Esposito E. (2006) Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies? Curr. Med. Chem. 13, 30693081.
  • Eberle-Wang K., Mikeladze Z., Uryu K. and Chesselet M. F. (1997) Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J. Comp. Neurol. 384, 233247.
  • Filip M., Bubar M. J. and Cunningham K. A. (2004) Contribution of serotonin 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J. Pharmacol. Exp. Ther. 310, 12461254.
  • Fox S. H., Chuang R. and Brotchie J. M. (2009) Serotonin and Parkinson's disease: on movement, mood, and madness. Mov. Disord. 24, 12551266.
  • Gerfen C. R. and Young W. S. (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460, 161167.
  • Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J., Jr and Sibley D. R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 14291432.
  • Gobert A., Rivet J. M., Lejeune F., Newman-Tancredi A., Adhumeau-Auclair A., Nicolas J. P., Cistarelli L., Melon C. and Millan M. J. (2000) Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36, 205221.
  • Grace A. A. and Bunney B. S. (1979) Paradoxical GABA excitation of nigral dopaminergic cells: Indirect mediation through reticulata inhibitory neurons. Eur. J. Pharmacol. 59, 211218.
  • Grace A. A. and Bunney B. S. (1985) Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res. 333, 271284.
  • Grofová I. (1975) The identification of striatal and pallidal neurons projecting to substantia nigra. Brain Res. 91, 286291.
  • Grofová I. and Rinvik E. (1970) An experimental electron microscopic study on the striatonigral projection in the cat. Exp. Brain Res. 11, 249262.
  • Gustafson A., King C. and Rey J. A. (2013) Lorcaserin (Belviq): a selective serotonin 5-HT2C agonist in the treatment of obesity. Pharm. Ther. 38, 525534.
  • Hajós M. and Greenfield S. A. (1993) Topographic heterogeneity of substantia nigra neurons: diversity in intrinsic membrane properties and synaptic inputs. Neuroscience 55, 919934.
  • Hajós M. and Greenfield S. A. (1994) Synaptic connections between pars compacta and pars reticulata neurones: electrophysiological evidence for functional modules within the substantia nigra. Brain Res. 660, 216224.
  • Hornykiewicz O. (1973) Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). Br. Med. Bull. 29, 172178.
  • Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. P. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 46, 157203.
  • Invernizzi R. W., Pierucci M., Calcagno E., Di Giovanni G., Di Matteo V., Benigno A. and Esposito E. (2007) Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study. Neuroscience 144, 15231535.
  • Jensen N. H., Cremers T. I. and Sotty F. (2010) Therapeutic potential of 5-HT2C receptor ligands. ScientificWorldJournal 10, 18701885.
  • Kennett G. A., Wood M. D., Bright F. et al. (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36, 609620.
  • Le Moine C., Normand B. and Bloch B. (1991) Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. Natl Acad. Sci. USA 88, 42054209.
  • Leggio G. M., Cathala A., Neny M., Rouge-Pont F., Drago F., Piazza P. V. and Spampinato U. (2009) In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist. J. Neurochemistry 111, 614623.
  • Leysen J. E., Geerts R., Gommeren W., Verwimp M. and Van Gompel P. (1982) Regional distribution of serotonin-2 receptor binding sites in the brain and effects of neuronal lesions. Arch. Int. Pharmacodyn. Ther. 256, 301305.
  • Liu S., Bubar M. J., Lanfranco M. F., Hillman G. R. and Cunningham K. A. (2007) Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience 146, 16771688.
  • Mailly P., Charpier S., Menterey A. and Deniau J. (2003) Three-dimensional organization of the recurrent axon collateral network of the substantia nigra pars reticulata neurons in the rat. J. Neurosci. 23, 52475257.
  • Millan M. J. (2005) Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie. 60, 441460.
  • Navailles S., Moison D., Ryczko D. and Spampinato U. (2006) Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors. J. Neurochem. 99, 13111319.
  • Nitsch C. and Riesenberg R. (1988) Immunocytochemical demonstration of GABAergic synaptic connections in rat substantia nigra after different lesions of the striatonigral projection. Brain Res. 461, 127142.
  • Nocjar C., Roth B. L. and Pehek E. A. (2002) Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience 111, 163176.
  • Oertel W. H. and Mugnaini E. (1984) Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci. Lett. 47, 233238.
  • Oertel W. H., Tappaz M. S., Berod A. and Mugnaini E. (1982) Two-color immunohistochemistry for dopamine and GABA neurons in rat substantia nigra and zona incerta. Brain Res. Bull. 9, 463474.
  • Opal M. D., Klenotich S. C., Morais M., Winle J., Doukas D., Kay L. J., Sousa N. and Dulawa S. M. (2013) Serotonin 2C receptor antagonists induce fast-onset antidepressant effects. Mol. Psychiatry. doi:10.1038/mp.2013.144 [Epub ahead of print].
  • Paladini C. A., Celada P. and Tepper J. M. (1999) Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo. Neuroscience 89, 799812.
  • Paxinos G. and Watson C. (1998) The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego.
  • Pehek E. A., Nocjar C., Roth B. L., Byrd T. A. and Mabrouk O. S. (2007) Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 31, 265277.
  • Porras G., Di Matteo V., Fracasso C., Lucas G., De Deurwaerdère P., Caccia S., Esposito E. and Spampinato U. (2002) 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26, 311324.
  • Ribak C. E., Vaughn J. E. and Roberts E. (1980) GABAergic nerve terminals decrease in the substantia nigra following hemitransections of the striatonigral and pallidonigral pathways. Brain Res. 192, 413420.
  • Rick C. E., Stanford I. M. and Lacey M. G. (1995) Excitation of rat substantia nigra pars reticulate neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine2C receptors. Neuroscience 69, 903913.
  • Roth B. (1994) Multiple serotonin receptors: clinical and experimental aspects. Ann. Clin. Psychiatry 6, 6778.
  • Santiago M. and Westerink B. H. (1992) The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats. Eur. J. Pharmacol. 219, 175181.
  • Shank E. J., Seitz P. K., Bubar M. J., Stutz S. J. and Cunningham K. A. (2007) Selective ablation of GABA neurons in the ventral tegmental area increases spontaneous locomotor activity. Behav. Neurosci. 121, 12241233.
  • Smith Y. and Bolam J. P. (1990) The output neurones and the dopaminergic neurones of the substantia nigra receive a GABA-containing input from the globus pallidus in the rat. J. Comp. Neurol. 296, 4764.
  • Soghomonian J. J. and Martin D. L. (1998) Two isoforms of glutamate decarboxylase: why”. Trends Pharm. Sci. 19, 500505.
  • Somogyi P., Bolam J. P., Totterdell S. and Smith A. D. (1981) Monosynaptic input from the nucleus accumbens-ventral striatum region to retrogradely labelled nigrostriatal neurones. Brain Res. 217, 245263.
  • Steiner H. and Gerfen C. R. (1998) Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res. 123, 6076.
  • Szydlowski S. N., Dorocic I. P., Planert H., Carlén M., Meletis K. and Silberberg G. (2013) Target selectivity of feedforward inhibition by striatal fast-spiking interneurons. J. Neurosci. 33, 16781683.
  • Tecott L. H., Sun L. M., Akana S. F., Strack A. M., Lowenstein D. H., Dallman M. F. and Julius D. (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374, 542546.
  • Tepper J. M. and Lee C. R. (1995) GABA-A receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J. Neurosci. 15, 30923103.
  • Tepper J. M. and Lee C. R. (2007) GABAergic control of substantia nigra dopaminergic neurons. Prog. Brain Res. 160, 189208.
  • Ward R. P. and Dorsa D. M. (1996) Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum. J. Comp. Neurol. 370, 405414.
  • Yamamoto B. K. and Pehek E. A. (1990) A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Res. 506, 236242.